A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol

European Journal of Anaesthesiology

Volumn 24, Issue 10, 2007, Pages 876-881

  Zhang, M Z ^a   Yu, Q ^a   Huang, Y L ^a   Wang, S J ^a   Wang, X R ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Anaesthetics, intravenous; Monitoring physiologic, bispectral index, auditory evoked potentials; Pharmacokinetics; Pharmacology; Propofol

Indexed keywords

PROPOFOL;

ADULT; ARTICLE; BISPECTRAL INDEX; BLOOD BRAIN BARRIER; CHINESE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG MONITORING; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; AGED; ANESTHETICS, INTRAVENOUS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL TRANSPORT; BRAIN; CHINA; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONITORING, INTRAOPERATIVE; PROPOFOL; PROSPECTIVE STUDIES;

EID: 36648999867     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507000890     Document Type: Article

References (26)

1. Egan TD. Target-controlled drug delivery: progress toward an intravenous 'vaporizer' and automated anesthetic administration. Anesthesiology 2003; 99: 1214-1219.
2. Shafer SL, Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentration at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharmaceut 1992; 20: 147-169.
3. Minto CF, Schnider TW, Gregg KM et al. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 2003; 99: 324-333.
4. e0) of propofol in children using the time to peak effect. Anesthesiology 2004; 101: 1269-1274.
5. e0s of propofol for blood pressure and EEG bispectral index in elderly and younger patients. Anesthesiology 1999; 90: 1517-1527.
6. Marsh B, White M, Morton N et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-48.
7. Schnider TW, Minto CF, Gambus PL et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-1182.
8. Tackley RM, Lewis GTR, Prys-Roberts C et al. Computer controlled infusion of propofol. Br J Anaesth 1989; 62: 46-53.
9. Shafer AS, Doze VA, Shafer SL et al. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348-356.
10. Schnider TW, Minto CF, Shafer SL et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-1516.
11. Flaishon R, Windsor A, Sigl J et al. Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique. Anesthesiology 1997; 86: 613-619.
12. Zhang MZ, Wu J, Wang SJ et al. The application and evaluation of target-controlled infusion propofol. CJA 2002; 22: 660-663 (in Chinese).
13. Zheng H, Cao XH, Wang J et al. The difference of targetcontrolled and measured propofol concentration. CJA 2003; 23: 822-825 (in Chinese).
14. Youngs EJ, Shafer SL. Basic pharmacokinetic and phaemacodynamic principles. In: White PF, ed. Textbook of intravenous anesthesia. Baltimore, USA: Williams & Wilkins Inc, 1997: 10-26.
15. Ludbrook GL, Visco E, Lam AM. Propofol: relations between brain concentrations, electroencephalogram, middle cerebral artery blood flow velocity, and cerebral oxygen extraction during induction of anesthesia. Anesthesiology 2002; 97: 1363-1370.
16. Critchley JA, Nimmo GR, Gregson CA et al. Intersubject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986; 22: 647-657.
17. Iron A, Groppi A, Flery B et al. Polymorphism of class I alcohol-dehydrogenase in French, Vietnamese and Niger populations: genotyping by PCR amplification and RFLP analysis of dried blood spot. Ann Genet 1992; 25: 152-156.
18. Ortolani O, Conti A, Sall-Ka B et al. The recovery of Senegalese African blacks from intravenous anesthesia with propofol and remifentanil is slower than that of Caucasians. Anesth Analg 2001; 93: 1222-1226.
19. Krejcie TC, Avram MJ. What determines anesthetic induction dose? It' the front-end kinetic, doctor! Anesth Analg 1999; 89: 541-544.
20. Litvan H, Jensen EW, Revuelta M et al. Comparison of auditory evoked potentials and the A-line ARX index for monitoring the hypnotic level during sevoflurane and propofol induction. Acta Anaesthesiol Scand 2002; 46: 245-251.
21. Gajraj RJ, Doi M, Mantzaridis H et al. Analysis of the EEG bispectrum, auditory evoked potentials and the EEG power spectrum during repeated transitions from consciousness to unconsciousness. Br J Anaesth 1998; 80: 46-52.
22. Glass PS, Bloom M, Kearse L et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86: 836-847.
23. Iselin-Chaves IA, Moalem HEEI, Gan TJ et al. Changes in the auditory evoked potentials and the bispectral index following propofol or propofol and alfentanil. Anesthesiology 2000; 92: 1300-1310.
24. Leslie K, Sessler D, Schroeder M et al. Propofol blood concentration and bispectral index predict suppression of learning during propofol/epidural anesthesia in volunteers. Anesth Analg 1995; 81: 1269-1274.
25. Gajraj RJ, Doi M, Mantzaridis H et al. Comparison of bispectral EEG analysis and auditory evoked potentials for monitoring depth of anaesthesia during propofol anaesthesia. Br J Anaesth 1999; 82: 672-678.
26. Wakeling HG, Zimmerman JB, Howell S et al. Targeting effect compartment or central compartment concentration: what predicts loss of consciousness? Anesthesiology 1999; 90: 92-97.